Claims for Patent: 8,034,994
✉ Email this page to a colleague
Summary for Patent: 8,034,994
Title: | Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants |
Abstract: | The present invention relates to the field of agricultural biotechnology. Disclosed herein are expression constructs with expression specificity for the starchy endosperm and/or the germinating embryo, transgenic plants comprising such expression constructs, and methods of making and using such DNA constructs and transgenic plants. |
Inventor(s): | Song; Hee-Sook (Raleigh, NC), Roche; Christina E. (Youngsville, NC), Dammann; Christian (Durham, NC) |
Assignee: | BASF Plant Science GmbH (Ludwigshafen, DE) |
Application Number: | 11/918,553 |
Patent Claims: | 1. A method for starchy-endosperm- and/or germinating embryo-specific expression of a nucleic acid sequence in a monocotyledonous plant, comprising: (a) constructing
an expression cassette by operably linking at least one transcription regulating nucleotide sequence to at least one nucleic acid sequence which is heterologous to said at least one transcription regulating nucleotide sequence, (b) transforming said
expression cassette into a monocotyledonous plant, and (c) selecting a transgenic plant demonstrating starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence, wherein the at least one transcription
regulating nucleotide sequence comprises a nucleotide sequence selected from the group consisting of: (i) the sequence of SEQ ID NO: 4; (ii) a fragment of the sequence of SEQ ID NO: 4, wherein the fragment directs starchy-endosperm- and/or germinating
embryo-specific expression of said at least one nucleic acid sequence; (iii) a nucleotide sequence having at least 95% sequence identity to the sequence SEQ ID NO: 4, wherein the nucleotide sequence comprises the DNA motifs provided in Table 9 and
directs starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence; (iv) a nucleotide sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 4, wherein the nucleotide sequence
further comprises the sequences of SEQ ID NO: 1 and SEQ ID NO: 2 and directs starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence; and (v) a nucleotide sequence which is complement or reverse
complement of any of the nucleotide sequence of (i) to (iv).
2. The method of claim 1, wherein the expression of said at least one nucleic acid sequence confers to the transgenic plant at least one trait or property selected from the group consisting of: (a) enhanced resistance against at least one stress factor, (b) increased nutritional quality of a seed or a sprout, (c) increased yield, and (d) excision of selection marker. 3. The method of claim 1, wherein said transcription regulating nucleotide sequence comprises a nucleotide sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 4, wherein the nucleotide sequence further comprises at least three copies of the sequence of SEQ ID NO: 1, and wherein the nucleotide sequence directs starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence. 4. The method of claim 1, wherein said transcription regulating nucleotide sequence comprises a nucleotide sequence having at least 95% sequence identity to the sequence of SEQ ID NO: 4, wherein the nucleotide sequence further comprises the sequence of SEQ ID NO: 3 and directs starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence. 5. The method of claim 1, wherein the at least one transcription regulating nucleotide sequence comprises a nucleotide sequence having at least 98% sequence identity to the sequence of SEQ ID NO: 4, and wherein the nucleotide sequence comprises the DNA motifs provided in Table 9 and directs starchy-endosperm- and/or germinating embryo-specific expression of said at least one nucleic acid sequence. 6. The method of claim 1, wherein said expression cassette does not comprise an intron with expression enhancing properties operably linked to said transcription regulating sequence. 7. The method of claim 2, wherein the enhanced resistance is against an abiotic or biotic stress factor. 8. The method of claim 7, wherein the enhanced resistance against a biotic stress factor is selected from the group consisting of fungal resistance, nematode resistance, insect resistance, viral resistance, and bacteria resistance. 9. The method of claim 7, wherein the enhanced resistance against an abiotic stress factor is selected from the group consisting of water stress resistance, drought resistance, cold resistance, salt resistance, high plant population density, and UV light resistance. 10. The method of claim 7, wherein the enhanced resistance is achieved by inducing early vigor. 11. The method of claim 1, wherein said at least one nucleic acid sequence encodes a polypeptide involved in phytohormone biosynthesis, phytohormone regulation, cell cycle regulation, or carbohydrate metabolism. 12. The method of claim 1, wherein said at least one nucleic acid sequence encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 6, 8, 10, 12, 14, 16, 18, 20, 22, 43, 45, 47, 49, 50, 51, or 53. 13. The method of claim 1, wherein said monocotyledonous plant is a maize, wheat, rice, barley, oat, rye, sorghum, banana, ryegrass or coix plant. 14. The method of claim 2, wherein the excision of selection marker is realized by: (a) inducing sequence deletion by side specific recombination using a site-specific recombinase, wherein said site-specific recombinase is expressed by said transcription regulating nucleotide sequence, or (b) inducing sequence deletion by induced homologous recombination, wherein the sequences to be deleted are flanked by sequences having an orientation, a sufficient length and a homology to each other to allow for homologous recombination between them, wherein homologous recombination is induced by a site-specific double-strand break made by a site-specific endonuclease, wherein said site-specific endonuclease is expressed by said transcription regulating nucleotide sequence. 15. The method of claim 1, wherein the expression of said at least one nucleic acid sequence results in expression of a protein, or expression of an antisense RNA, sense or double-stranded RNA. |
Details for Patent 8,034,994
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2025-04-19 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2025-04-19 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2025-04-19 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.